Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy

References

• van der HageJAMieogJSvan de VijverMJvan de VeldeCJEuropean Organization for Research and Treatment of CancerEfficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysisBreast Cancer Res200795R7017931406
   PubMed Web of Science ®Google Scholar
• GolshanMCirrincioneCTSikovWMImpact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)Breast Cancer Res Treat2016160229730427704226
   PubMed Web of Science ®Google Scholar
• RastogiPAndersonSJBearHDPreoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27J Clin Oncol200826577878518258986
   PubMed Web of Science ®Google Scholar
• HayesDFSchottAFNeoadjuvant chemotherapy: what are the benefits for the patient and for the investigator?J Natl Cancer Inst Monogr2015201551363926063884
   PubMedGoogle Scholar
• KümmelSHoltschmidtJLoiblSSurgical treatment of primary breast cancer in the neoadjuvant settingBr J Surg2014101891292424838656
   PubMed Web of Science ®Google Scholar
• BearHDAndersonSSmithRESequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27J Clin Oncol200624132019202716606972
   PubMed Web of Science ®Google Scholar
• GralowJRBursteinHJWoodWPreoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable diseaseJ Clin Oncol200826581481918258991
   PubMed Web of Science ®Google Scholar
• ClarkeMCollinsRDarbySEffects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsLancet200536695032087210616360786
   PubMed Web of Science ®Google Scholar
• HuangEHTuckerSLStromEAPostmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomyJ Clin Oncol200422234691469915570071
   PubMed Web of Science ®Google Scholar
• McguireSEGonzalez-AnguloAMHuangEHPostmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapyInt J Radiat Oncol Biol Phys20076841004100917418973
   PubMed Web of Science ®Google Scholar
• NagarHMittendorfEAStromEALocal-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancerInt J Radiat Oncol Biol Phys201181378278721885207
   PubMed Web of Science ®Google Scholar
• FrancisSRFrandsenJKokenyKEGaffneyDKPoppeMMOutcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancersBreast20173215616128193571
   PubMed Web of Science ®Google Scholar
• TrovoMDurofilEPoleselJLocoregional failure in early-stage breast cancer patients treated with radical mastectomy and adjuvant systemic therapy: which patients benefit from postmastectomy irradiation?Int J Radiat Oncol Biol Phys2012832e153e15722386375
   PubMed Web of Science ®Google Scholar
• HamamotoYOhsumiSAogiKAre there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy?Breast Cancer201421217718222569681
   PubMed Web of Science ®Google Scholar
• FowbleBLEinckJPKimDNRole of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancerInt J Radiat Oncol Biol Phys201283249450322579377
   PubMed Web of Science ®Google Scholar
• GargAKStromEAMcNeeseMDT3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapyInt J Radiat Oncol Biol Phys200459113814515093909
   PubMed Web of Science ®Google Scholar
• GargAKOhJLOswaldMJEffect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomyInt J Radiat Oncol Biol Phys20076951478148317855016
   PubMed Web of Science ®Google Scholar
• HennessyBTHortobagyiGNRouzierROutcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapyJ Clin Oncol200523369304931116361629
   PubMed Web of Science ®Google Scholar
• RouzierRPusztaiLDelalogeSNomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancerJ Clin Oncol200523338331833916293864
   PubMed Web of Science ®Google Scholar
• JerussJSMittendorfEATuckerSLCombined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapyJ Clin Oncol200826224625218056680
   PubMed Web of Science ®Google Scholar
• VilaJTeshomeMTuckerSLCombining clinical and pathologic staging variables has prognostic value in predicting local-regional recurrence following neoadjuvant chemotherapy for breast cancerAnn Surg2017265357458027735826
   PubMed Web of Science ®Google Scholar
• Le ScodanRSelzJStevensDRadiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomyInt J Radiat Oncol Biol Phys2012821e1e721377284
   PubMed Web of Science ®Google Scholar
• ShimSJParkWHuhSJThe role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05)Int J Radiat Oncol Biol Phys2014881657224161425
   PubMed Web of Science ®Google Scholar
• CaoLOuDShenKWOutcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancerCancer Radiother2018221384429306555
   PubMed Web of Science ®Google Scholar